124 related articles for article (PubMed ID: 27175594)
61. The IRX1/HOXA connection: insights into a novel t(4;11)- specific cancer mechanism.
Kühn A; Löscher D; Marschalek R
Oncotarget; 2016 Jun; 7(23):35341-52. PubMed ID: 27175594
[TBL] [Abstract][Full Text] [Related]
62. HOXA9/IRX1 expression pattern defines two subgroups of infant MLL-AF4-driven acute lymphoblastic leukemia.
Symeonidou V; Ottersbach K
Exp Hematol; 2021 Jan; 93():38-43.e5. PubMed ID: 33069783
[TBL] [Abstract][Full Text] [Related]
63. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
[TBL] [Abstract][Full Text] [Related]
64. A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification.
Bueno C; Montes R; Melen GJ; Ramos-Mejia V; Real PJ; Ayllón V; Sanchez L; Ligero G; Gutierrez-Aranda I; Fernández AF; Fraga MF; Moreno-Gimeno I; Burks D; Plaza-Calonge Mdel C; Rodríguez-Manzaneque JC; Menendez P
Cell Res; 2012 Jun; 22(6):986-1002. PubMed ID: 22212479
[TBL] [Abstract][Full Text] [Related]
65. Molecular mechanisms of MLL-associated leukemia.
Yokoyama A
Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519
[TBL] [Abstract][Full Text] [Related]
66. HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL.
Starkova J; Zamostna B; Mejstrikova E; Krejci R; Drabkin HA; Trka J
Pediatr Blood Cancer; 2010 Dec; 55(6):1072-82. PubMed ID: 20672366
[TBL] [Abstract][Full Text] [Related]
67. When one mutation is all it takes.
Greaves M
Cancer Cell; 2015 Apr; 27(4):433-4. PubMed ID: 25873168
[TBL] [Abstract][Full Text] [Related]
68. Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.
Park SM; Gönen M; Vu L; Minuesa G; Tivnan P; Barlowe TS; Taggart J; Lu Y; Deering RP; Hacohen N; Figueroa ME; Paietta E; Fernandez HF; Tallman MS; Melnick A; Levine R; Leslie C; Lengner CJ; Kharas MG
J Clin Invest; 2015 Mar; 125(3):1286-98. PubMed ID: 25664853
[TBL] [Abstract][Full Text] [Related]
69. Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines.
Kowarz E; Löscher D; Marschalek R
Biotechnol J; 2015 Apr; 10(4):647-53. PubMed ID: 25650551
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of class I HDACs abrogates the dominant effect of MLL-AF4 by activation of wild-type MLL.
Ahmad K; Katryniok C; Scholz B; Merkens J; Löscher D; Marschalek R; Steinhilber D
Oncogenesis; 2014 Nov; 3(11):e127. PubMed ID: 25402609
[TBL] [Abstract][Full Text] [Related]
71. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation.
Scheicher R; Hoelbl-Kovacic A; Bellutti F; Tigan AS; Prchal-Murphy M; Heller G; Schneckenleithner C; Salazar-Roa M; Zöchbauer-Müller S; Zuber J; Malumbres M; Kollmann K; Sexl V
Blood; 2015 Jan; 125(1):90-101. PubMed ID: 25342715
[TBL] [Abstract][Full Text] [Related]
72. Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.
Yu H; Neale G; Zhang H; Lee HM; Ma Z; Zhou S; Forget BG; Sorrentino BP
Blood; 2014 Sep; 124(11):1737-47. PubMed ID: 25082879
[TBL] [Abstract][Full Text] [Related]
73. Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.
Placke T; Faber K; Nonami A; Putwain SL; Salih HR; Heidel FH; Krämer A; Root DE; Barbie DA; Krivtsov AV; Armstrong SA; Hahn WC; Huntly BJ; Sykes SM; Milsom MD; Scholl C; Fröhling S
Blood; 2014 Jul; 124(1):13-23. PubMed ID: 24764564
[TBL] [Abstract][Full Text] [Related]
74. PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.
Zhou J; Wu J; Li B; Liu D; Yu J; Yan X; Zheng S; Wang J; Zhang L; Zhang L; He F; Li Q; Chen A; Zhang Y; Zhao X; Guan Y; Zhao X; Yan J; Ni J; Nobrega MA; Löwenberg B; Delwel R; Valk PJ; Kumar A; Xie L; Tenen DG; Huang G; Wang QF
Leukemia; 2014 Jul; 28(7):1436-48. PubMed ID: 24445817
[TBL] [Abstract][Full Text] [Related]
75. Shikonin induces cell cycle arrest in human gastric cancer (AGS) by early growth response 1 (Egr1)-mediated p21 gene expression.
Kim SJ; Kim JM; Shim SH; Chang HI
J Ethnopharmacol; 2014 Feb; 151(3):1064-1071. PubMed ID: 24384380
[TBL] [Abstract][Full Text] [Related]
76. Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells.
Huang X; Spencer GJ; Lynch JT; Ciceri F; Somerville TD; Somervaille TC
Leukemia; 2014 May; 28(5):1081-91. PubMed ID: 24166297
[TBL] [Abstract][Full Text] [Related]
77. An alternative splice process renders the MLL protein either into a transcriptional activator or repressor.
Rössler T; Marschalek R
Pharmazie; 2013 Jul; 68(7):601-7. PubMed ID: 23923644
[TBL] [Abstract][Full Text] [Related]
78. BMI1 represses Ink4a/Arf and Hox genes to regulate stem cells in the rodent incisor.
Biehs B; Hu JK; Strauli NB; Sangiorgi E; Jung H; Heber RP; Ho S; Goodwin AF; Dasen JS; Capecchi MR; Klein OD
Nat Cell Biol; 2013 Jul; 15(7):846-52. PubMed ID: 23728424
[TBL] [Abstract][Full Text] [Related]
79. The MLL recombinome of acute leukemias in 2013.
Meyer C; Hofmann J; Burmeister T; Gröger D; Park TS; Emerenciano M; Pombo de Oliveira M; Renneville A; Villarese P; Macintyre E; Cavé H; Clappier E; Mass-Malo K; Zuna J; Trka J; De Braekeleer E; De Braekeleer M; Oh SH; Tsaur G; Fechina L; van der Velden VH; van Dongen JJ; Delabesse E; Binato R; Silva ML; Kustanovich A; Aleinikova O; Harris MH; Lund-Aho T; Juvonen V; Heidenreich O; Vormoor J; Choi WW; Jarosova M; Kolenova A; Bueno C; Menendez P; Wehner S; Eckert C; Talmant P; Tondeur S; Lippert E; Launay E; Henry C; Ballerini P; Lapillone H; Callanan MB; Cayuela JM; Herbaux C; Cazzaniga G; Kakadiya PM; Bohlander S; Ahlmann M; Choi JR; Gameiro P; Lee DS; Krauter J; Cornillet-Lefebvre P; Te Kronnie G; Schäfer BW; Kubetzko S; Alonso CN; zur Stadt U; Sutton R; Venn NC; Izraeli S; Trakhtenbrot L; Madsen HO; Archer P; Hancock J; Cerveira N; Teixeira MR; Lo Nigro L; Möricke A; Stanulla M; Schrappe M; Sedék L; Szczepański T; Zwaan CM; Coenen EA; van den Heuvel-Eibrink MM; Strehl S; Dworzak M; Panzer-Grümayer R; Dingermann T; Klingebiel T; Marschalek R
Leukemia; 2013 Nov; 27(11):2165-76. PubMed ID: 23628958
[TBL] [Abstract][Full Text] [Related]
80. Dynamic HoxB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells.
Fan R; Bonde S; Gao P; Sotomayor B; Chen C; Mouw T; Zavazava N; Tan K
Blood; 2012 May; 119(19):e139-47. PubMed ID: 22438249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
